NCT07348991
- Conditions
- Arrhythmia, Sinus, Arrhythmias, Cardiac, Atrial Fibrillation, +17 more
- Locations
-
Not specified
Clinical trial condition
Neoplastic Processes
Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.
3,267 public trials
689 recruiting studies
Neoplastic Processes trial results
Not Yet Recruiting
The Association Between Deep Endometriosis and the Occurrence of Colorectal Carcinoma
NCT07386431
- Conditions
- Bowel Endometriosis, Carcinogenesis, Colon Resection, +26 more
- Locations
-
Not specified
Not Yet Recruiting
Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer
NCT07382505
- Conditions
- Cervical Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +16 more
- Locations
-
- Asan Medical Center Seoul, South Korea
Not Yet Recruiting
18F-FAPI PET in Cancers of Unknown Primary Site
NCT07372963
- Conditions
- Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Not Yet Recruiting
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
NCT07363330
- Conditions
- Cervical Cancer, Disease Attributes, Female Urogenital Diseases, +19 more
- Locations
-
- Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
Not Yet Recruiting
The NorCUP Trial: Improving Prognosis and Personalized Treatment in Cancer of Unknown Primary (CUP)
NCT07366008
- Conditions
- Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- Haukeland University Hospital Bergen, Norway
- Akershus University Hospital Oslo, Norway
- Oslo University Hospital Oslo, Norway
- Stavanger University Hospital Stavanger, Norway
Not Yet Recruiting
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC
NCT07350824
- Conditions
- Disease Attributes, HCC, Minimal Residual Disease, +6 more
- Locations
-
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not Yet Recruiting
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
NCT07348107
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Verspeeten Family Cancer Centre London, Ontario, Canada
Not Yet Recruiting
Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer
NCT07112612
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
NCT06660862
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
- o University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States